Per Ole M. Gundersen

Norwegian University of Science and Technology, St Olav's University Hospital

Papers

Total Citations

H-Index

About

Per Ole M. Gundersen is a leading figure in the field of analytical toxicology and clinical pharmacology, with a primary focus on the detection and quantification of drugs and their metabolites in biological matrices. His major contributions center on developing advanced, highly sensitive methods using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS) and time-of-flight mass spectrometry (QTOF-MS). Notably, his work on synthetic cannabinoids—a rapidly evolving class of new psychoactive substances (NPS)—has been instrumental in enabling the screening, quantification, and confirmation of their metabolites in urine, a critical tool for forensic and clinical toxicology. This landmark study has garnered 38 citations, underscoring its impact on public health and drug monitoring. Gundersen has also advanced therapeutic drug monitoring by creating a robust method for the simultaneous quantification of 21 antihypertensive drugs in serum, a 25-citation achievement that aids in personalized medicine and compliance assessment. His research is characterized by its practical application, bridging the gap between cutting-edge analytical chemistry and real-world clinical and forensic needs. Through these contributions, Gundersen has established himself as a key innovator in the fight against emerging drug threats and in improving patient care.